Canada Corporation Registry

PROBIONASE THERAPIES INC.

THÉRAPIES PROBIONASE INC.

Dissolution pending Federal corporation 9607862 Montreal, QC Since 2016 Checked Nov 17, 2026

Dissolution pending

Corporations Canada has marked this corporation for dissolution because its annual returns have not been filed. To avoid dissolution, the overdue returns need to be filed.

PROBIONASE THERAPIES INC. is a federal corporation with dissolution pending (corporation number 9607862). Its business number is 765487095. It was incorporated on Jun 10, 2016 under the Canada Business Corporations Act and its registered office is in Montreal, Quebec. Annual returns for 2025 and 2026 are overdue. It has one director on record.

Corporate details

Corporation number
9607862
Business number
765487095
Status
Dissolution pending Annual filings overdue
Governing law
Canada Business Corporations Act
Incorporated
Jun 10, 2016
Corporation type
Non-distributing corporation with 50 or fewer shareholdersAs declared in its 2024 annual return.
Registered office
1151 Boulevard Mont Royal
Montreal QC H2V 2H6
Number of directors
At least 1, at most 10As the articles allow.

Annual filings

Anniversary date
Jun 10The date of incorporation, amalgamation or continuance.
Annual filing period
Jun 10 to Aug 9 each year
Last annual meeting
Jul 9, 2024
Annual returns by year
YearAnnual returnAnnual meeting
2026Overdue
2025Overdue
2024FiledJul 9, 2024

The last annual return filed, and each year since.

Directors

Loading the directors from the federal record...

Names

Names in use
NameFormIn use since
PROBIONASE THERAPIES INC.NameJun 10, 2016
THÉRAPIES PROBIONASE INC.Other-language formJun 10, 2016

Filings and certificates

Filings and certificates
WhatDate
IncorporatedJun 10, 2016

Registered in a province as well? Find provincial registrations(opens in a new tab). Something wrong or out of date? Request a correction.